Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton

Lifeward Ltd. (LFWD) recently announced that it has received FDA 510(k) clearance for its latest innovation, the ReWalk 7 Exoskeleton. This next-generation wearable device is designed to help individuals with spinal cord injuries (SCI) stand and walk, featuring new and enhanced functionalities aimed at improving user experience and mobility outcomes.The FDA clearance marks a significant milestone for Lifeward, reinforcing its leadership in the medical exoskeleton market. With prior regulatory and reimbursem ...